http://orcid.org/0000-0002-8073-2441
References
- Allyse M, Minear MA, Berson E, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health. 2015;7:113–126.
- PubMed. Bethesda: US National Library of Medicine, National Center for Biotechnology Information. 1996 [cited 2018 Apr 25], Available from: https://www.ncbi.nlm.nih.gov/pubmed/
- Google. Menlo Park. 1998. [cited 2018 Apr 25]. Available from: https://trends.google.com/trends/
- American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol. 2012;120:1532–1534.
- Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. J Genet Counsel. 2013;22:291.
- Benn P, Borell A, Chiu R, et al. Position statement from the aneuploidy screening committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2013;33:622–629.
- Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013;15:395–398.
- Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol. 2012;207:374e1–374e6.
- Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;370:799–808.
- Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589–1597.
- Benn P, Borrell A, Chiu RW, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn. 2015;35:725–734.
- Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy. Obstet Gynecol. 2015;126:e31–e37.
- Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:1056–1065.
- Larion S, Warsof SL, Romary L, et al. Use of the combined first-trimester screen in high- and low-risk patient populations after introduction of noninvasive prenatal testing. J Ultrasound Med. 2015;34:1423–1428.
- Hui L, Muggli EE, Halliday JL. Population-based trends in prenatal screening and diagnosis for aneuploidy: a retrospective analysis of 38 years of state-wide data. BJOG. 2016;123:90–97.
- “Roche’s Ariosa Harmony Noninvasive Prenatal Test Gets Coverage From Large Private Insurers in US.” GenomeWeb. [cited 2016 May 3]. Available from: https://www.genomeweb.com/molecular-diagnostics/roches-ariosa-harmony-noninvasive-prenatal-test-gets-coverage-large-private.
- Oepkes D, Page-Christiaens GC, Bax CJ, et al. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact. Prenat Diagn. 2016;36:1083–1090.
- Institut national d’assurance maladie-invalidite. [cited 2017 June 30]. Available from: http://www.riziv.fgov.be/fr/nouvelles/Pages/remboursement-test-prenatal-non-invasif.aspx.
- Martin JA, Hamilton BE, Osterman MJ, et al. Births: final data for 2016. Natl Vital Stat Rep. 2018;67:1–55.
- Office for National Statistics. Statistical bulletin: births in England and Wales. 2016 [cited 2018 Apr 25]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/bulletins/birthsummarytablesenglandandwales/2016.